GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications

scientific article published on 10 August 2016

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2016/4358292
P932PMC publication ID4995330
P698PubMed publication ID27594734

P50authorFilippo MartignanoQ50935945
Flavia FocaQ52958617
Samanta SalviQ57077641
Giorgia GurioliQ86590574
Valentina CasadioQ87983305
Ugo De GiorgiQ88923334
Matteo CostantiniQ96254230
Daniele CalistriQ38641368
P2093author name stringRoberta Gunelli
P2860cites workGlutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell linesQ27853038
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cellsQ28363395
Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosisQ33909418
Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell deathQ34123770
DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.Q34249360
Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysisQ35108310
Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysisQ35678704
Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.Q35846508
Molecular detection of prostate cancer: a role for GSTP1 hypermethylationQ35913110
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesisQ35933390
Epigenetic markers for molecular detection of prostate cancerQ36746201
The epigenetic promise for prostate cancer diagnosisQ37967574
DNA methylation changes in prostate cancer.Q37987501
Glutathione S-transferase-pi protein expression in prostate cancer--not always a useful diagnostic toolQ56970331
CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarkerQ73418972
High-grade prostatic intraepithelial neoplasiaQ80295827
Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimensQ85781880
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies?Q38100547
The study of DNA methylation in urological cancer: present and future.Q38104113
Cancer development, progression, and therapy: an epigenetic overview.Q38154977
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conferenceQ38230103
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell deathQ38241806
Meta-analyses of methylation markers for prostate cancerQ39155363
GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastomaQ39449319
Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancerQ40890580
Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a RebiopsyQ41207861
Application of combined immunohistochemical panel of AMACR(P504S)/p63 cocktail, cytokeratin 5 and D2-40 to atypical glands in prostatic needle biopsyQ42470183
Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancerQ44108405
Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasiaQ47242342
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P304page(s)4358292
P577publication date2016-08-10
P1433published inDisease MarkersQ15756044
P1476titleGSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
P478volume2016

Reverse relations

cites work (P2860)
Q98178219Aberrant SOCS3 Promoter Methylation as a Noninvasive Diagnostic Biomarker for Locally Advanced Prostate Cancer
Q92133146Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk
Q99591000Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
Q90459573Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer
Q60534631GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity
Q90397374GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk
Q52728695High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma.
Q42687929Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis
Q92211919Racial disparities, cancer and response to oxidative stress
Q89637860Targeted nanopore sequencing with Cas9-guided adapter ligation
Q47379977The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Q49546811The molecular biology of prostate cancer: current understanding and clinical implications

Search more.